Patel Samir Rashmikant
SEC CIK 1702447 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | Dir, 10% | 98.2K | — | — | 11 | 2024-05-31 | 2026-07-07 |
Most active insiders at AKTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farag Kameel D. | Interim CFO | — | — |
| 2 | Patel Samir Rashmikant | Dir, 10% | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-07-17 06:03 | 2026-07-07 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir, 10% | M - OptEx | $0.4307 | +22.5K | 98.2K | +30% | +$9,681 |
| DI | 2025-03-10 | 2025-03-06 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $1.12 | +406.2K | 3.03M | +15% | +$455.0K |
| DI | 2025-01-07 | 2025-01-03 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +208.0K | 5.25B | +0.0% | $0 |
| MI | 2024-12-30 | 2024-12-26+ | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +3.60M | 5.25B | +0.1% | $0 |
| I | 2024-12-27 | 2024-12-24 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +7.50M | 5.25B | +0.1% | $0 |
| I | 2024-12-26 | 2024-12-20 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +1.40M | 5.24B | +0.0% | $0 |
| I | 2024-12-26 | 2024-12-23 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +1.40M | 5.24B | +0.0% | $0 |
| DI | 2024-12-03 | 2024-12-02 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +419.29M | 5.24B | +9% | $0 |
| I | 2024-11-18 | 2024-11-14 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | — | +1.40B | 4.82B | +41% | — |
| 2024-07-02 | 2024-06-30 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +91.40M | 91.40M | New | $0 | |
| DI | 2024-06-04 | 2024-05-31 | AKTX | Akari Therapeutics Plc | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +1.33B | 3.41B | +64% | $0 |
Purchase Sale Sale after option exercise All abbreviations